SCHEMBL2789012

SCHEMBL2789012

Nc1ccc(-c2ccc(F)cc2)cc1C(=O)O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.78
KDM4E B2RXH2 3/20 0.78
GFER P55789 1/20 0.78
RXFP1 Q9HBX9 1/20 0.78
KEAP1 Q14145 1/20 0.72
IKBKB O14920 1/20 0.56
MCL1 Q07820 3/20 0.53
MEN1 O00255 2/20 0.53
USP2 O75604 2/20 0.53
POLB P06746 1/20 0.53
MAPT P10636 1/20 0.53
THRB P10828 1/20 0.53
PKM P14618 1/20 0.53
APEX1 P27695 1/20 0.53
RECQL P46063 1/20 0.53
BLM P54132 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
BCL2L1 Q07817 2/20 0.52
BAD Q92934 2/20 0.52
GLA P06280 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3865083 0.90 KMT2A (0.95) KMT2AKDM4EGFERRXFP1KEAP1
SCHEMBL1954450 0.88 KMT2A (1.00) KMT2AKDM4EGFERRXFP1KEAP1
SCHEMBL29498389 0.88 KMT2A (1.00) KMT2AKDM4EGFERRXFP1KEAP1
SCHEMBL352643 0.88 KMT2A (1.00) KMT2AKDM4EGFERRXFP1KEAP1
Hydrochloric Acid SCHEMBL8024368 0.86 KMT2A (0.95) KMT2AKDM4EGFERRXFP1KEAP1
Water SCHEMBL28033099 0.86 KMT2A (0.95) KMT2AKDM4EGFERRXFP1KEAP1
Ammonia Solution, Strong SCHEMBL5271744 0.86 KMT2A (0.95) KMT2AKDM4EGFERRXFP1KEAP1
Methane SCHEMBL29001097 0.86 KMT2A (0.95) KMT2AKDM4EGFERRXFP1KEAP1
SCHEMBL5308529 0.85 IKBKB (0.71) KMT2AKDM4EGFERRXFP1KEAP1
SCHEMBL21857594 0.85 PPM1B (0.67) KMT2AKDM4EGFERRXFP1KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152455-A1 ORGANOMETALIC COMPOUNDS FOR ELECTROLUMINESCENCE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME GRACEL DISPLAY INC. (KR) 2010-06-17 US disclosed
CN-101641423-A Organometallic compound for electroluminescence and organic electroluminescent device using the same GRACEL DISPLAY INC KR 2010-02-03 CN disclosed
EP-2092040-A1 ORGANOMETALIC COMPOUNDS FOR ELECTROLUMINESCENCE AND ORGANIC ELECTROLUMIESCENT DEVICE USING THE SAME Gracel Display Inc. (KR) 2009-08-26 EP disclosed
WO-2008082249-A1 ORGANOMETALIC COMPOUNDS FOR ELECTROLUMINESCENCE AND ORGANIC ELECTROLUMIESCENT DEVICE USING THE SAME GRACEL DISPLAY INC. (KR) 2008-07-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152455-A1 ORGANOMETALIC COMPOUNDS FOR ELECTROLUMINESCENCE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME EPCAM, ORC3, L1CAM KMT2A 337/4885KDM4E 1193/4885GFER 1379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.